ArticleDiagnostics (Basel, Switzerland)2022

Identification of MicroRNAs as Potential Blood-Based Biomarkers for Diagnosis and Therapeutic Monitoring of Active Tuberculosis.

Junseong Kim et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.